Compares a new bedside electrolyte test with a standard analyzer in emergency patients
Compares a new bedside electrolyte device with a standard analyzer in emergency patients.
Plain-language title generated from the registry record
Registry title: Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
Key facts
- Where
- Guangzhou, ChinaSee the site
Where in China
- Zhujiang Hospital, Southern Medical University OrganizationGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Zhujiang Hospital
- Trial code
- NCT06726460
- Record updated
- 18 July 2025
- Original description
The goal of this study is to compare the performance of a novel Point-of-Care Testing (POCT) dry electrolyte analyzer (P1) with the Nova Stat Profile pHOx Ultra Analyzer System (Nova) in an acute care setting. The main questions it aims to answer are:Read full original descriptionShow less
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting: A Cross-Sectional Study
The goal of this study is to compare the performance of a novel Point-of-Care Testing (POCT) dry electrolyte analyzer (P1) with the Nova Stat Profile pHOx Ultra Analyzer System (Nova) in an acute care setting. The main questions it aims to answer are:
1. How consistent are the results between P1 and Nova in the emergency setting, including outliers, correlation, linearity, and bias? 2. Whether P1 can serve as a suitable alternative to Nova in the acute care setting for electrolyte measurement in the emergency environment.
Participants will be patients in the emergency department who will undergo simultaneous measurement with P1 and Nova during their emergency care to assess the performance of both devices.
Additionally, the study will investigate electrolyte levels in emergency patients, focusing on the prevalence of abnormal ionized magnesium (iMg2+) levels, the correlation between iMg2+ and total magnesium (tMg), and the clinical significance of iMg2+ measurement.
Inclusion: Patients who are scheduled to undergo electrolyte measuring in the emergency department (ED) or emergency intensive care unit (ICU).
Exclusion: Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc; Missing residual sample types (serum or whole blood); Patients whose residual blood samples are not tested within the specified time frame after collection; Other patients deemed ineligible by the investigator.